标题
Immune profiling of pediatric solid tumors
作者
关键词
-
出版物
JOURNAL OF CLINICAL INVESTIGATION
Volume 130, Issue 7, Pages 3391-3402
出版商
American Society for Clinical Investigation
发表日期
2020-06-15
DOI
10.1172/jci137181
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
- (2019) Jérôme Galon et al. NATURE REVIEWS DRUG DISCOVERY
- Multidimensional intratumour heterogeneity in neuroblastoma
- (2019) Kristoffer von Stedingk et al. Oncotarget
- Association of Tumor Microenvironment T-Cell Repertoire and Mutational Load With Clinical Outcome After Sequential Checkpoint Blockade in Melanoma
- (2019) Erik Yusko et al. Cancer Immunology Research
- The genomic landscape of pediatric cancers: Implications for diagnosis and treatment
- (2019) E. Alejandro Sweet-Cordero et al. SCIENCE
- A Single-Cell Atlas of the Tumor and Immune Ecosystem of Human Breast Cancer
- (2019) Johanna Wagner et al. CELL
- Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial
- (2019) Tony S K Mok et al. LANCET
- High-dimensional cytometric analysis of colorectal cancer reveals novel mediators of antitumour immunity
- (2019) Natasja L de Vries et al. GUT
- Emerging trends in immunotherapy for pediatric sarcomas
- (2019) Kyle A. Dyson et al. Journal of Hematology & Oncology
- CD163+ immune cell infiltrates and presence of CD54+ microvessels are prognostic markers for patients with embryonal rhabdomyosarcoma
- (2019) Jakob Nikolas Kather et al. Scientific Reports
- Pembrolizumab in paediatric patients with advanced melanoma or a PD-L1-positive, advanced, relapsed, or refractory solid tumour or lymphoma (KEYNOTE-051): interim analysis of an open-label, single-arm, phase 1–2 trial
- (2019) Birgit Geoerger et al. LANCET ONCOLOGY
- Multicenter harmonization study for PD-L1 IHC testing in non-small-cell lung cancer
- (2018) J Adam et al. ANNALS OF ONCOLOGY
- Medulloblastoma: From Molecular Subgroups to Molecular Targeted Therapies
- (2018) Jun Wang et al. Annual Review of Neuroscience
- Molecular, Pathological, Radiological, and Immune Profiling of Non-brainstem Pediatric High-Grade Glioma from the HERBY Phase II Randomized Trial
- (2018) Alan Mackay et al. CANCER CELL
- Quantifying tumor-infiltrating immune cells from transcriptomics data
- (2018) Francesca Finotello et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Single-Cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment
- (2018) Elham Azizi et al. CELL
- Clinically Relevant Cytotoxic Immune Cell Signatures and Clonal Expansion of T Cell Receptors in High-riskMYCN-not-amplified Human Neuroblastoma
- (2018) Jun S. Wei et al. CLINICAL CANCER RESEARCH
- A retrospective study of bevacizumab for treatment of brainstem glioma with malignant features
- (2018) Shigeta Moriya et al. JOURNAL OF CLINICAL NEUROSCIENCE
- Phase II, Open-Label, Randomized, Multicenter Trial (HERBY) of Bevacizumab in Pediatric Patients With Newly Diagnosed High-Grade Glioma
- (2018) Jacques Grill et al. JOURNAL OF CLINICAL ONCOLOGY
- Next generation of immune checkpoint therapy in cancer: new developments and challenges
- (2018) Julian A. Marin-Acevedo et al. Journal of Hematology & Oncology
- Immunophenotyping of pediatric brain tumors: correlating immune infiltrate with histology, mutational load, and survival and assessing clonal T cell response
- (2018) Ashley S. Plant et al. JOURNAL OF NEURO-ONCOLOGY
- High programmed cell death 1 ligand–1 expression: association with CD8+ T-cell infiltration and poor prognosis in human medulloblastoma
- (2018) Daiki Murata et al. JOURNAL OF NEUROSURGERY
- PD-L1 Immunohistochemistry Comparability Study in Real-Life Clinical Samples: Results of Blueprint Phase 2 Project
- (2018) Ming Sound Tsao et al. Journal of Thoracic Oncology
- International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study
- (2018) Franck Pagès et al. LANCET
- The landscape of genomic alterations across childhood cancers
- (2018) Susanne N. Gröbner et al. NATURE
- Four evolutionary trajectories underlie genetic intratumoral variation in childhood cancer
- (2018) Jenny Karlsson et al. NATURE GENETICS
- Understanding the tumor immune microenvironment (TIME) for effective therapy
- (2018) Mikhail Binnewies et al. NATURE MEDICINE
- High-dimensional single-cell analysis predicts response to anti-PD-1 immunotherapy
- (2018) Carsten Krieg et al. NATURE MEDICINE
- Specific expression of PD-L1 in RELA-fusion supratentorial ependymoma: Implications for PD-1-targeted therapy
- (2018) Davis A. Witt et al. PEDIATRIC BLOOD & CANCER
- Immune profiles of desmoplastic small round cell tumor and synovial sarcoma suggest different immunotherapeutic susceptibility upfront compared to relapse specimens
- (2018) Mary Frances Wedekind et al. PEDIATRIC BLOOD & CANCER
- Combining chemotherapy with PD-1 blockade in NSCLC
- (2018) Matthen Mathew et al. PHARMACOLOGY & THERAPEUTICS
- Gliomas in Children
- (2018) Dominik Sturm et al. SEMINARS IN NEUROLOGY
- Multiplex immunohistochemistry accurately defines the immune context of metastatic melanoma
- (2018) H. Halse et al. Scientific Reports
- Development of PD-1 and PD-L1 inhibitors as a form of cancer immunotherapy: a comprehensive review of registration trials and future considerations
- (2018) Jun Gong et al. Journal for ImmunoTherapy of Cancer
- Pan-cancer adaptive immune resistance as defined by the Tumor Inflammation Signature (TIS): results from The Cancer Genome Atlas (TCGA)
- (2018) Patrick Danaher et al. Journal for ImmunoTherapy of Cancer
- Non-inflammatory tumor microenvironment of diffuse intrinsic pontine glioma
- (2018) Grant L. Lin et al. Acta Neuropathologica Communications
- From Cancer Immune Surveillance to Cancer Immunoediting: Birth of Modern Immuno-Oncology
- (2018) Wolf H. Fridman JOURNAL OF IMMUNOLOGY
- TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells
- (2018) Sanjeev Mariathasan et al. NATURE
- Characterization of the immune microenvironment of diffuse intrinsic pontine glioma: Implications for development of immunotherapy
- (2018) Nicole A P Lieberman et al. NEURO-ONCOLOGY
- Profiling targetable immune checkpoints in osteosarcoma
- (2018) Troy A McEachron et al. OncoImmunology
- Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma
- (2018) Moshe Sade-Feldman et al. CELL
- T-Cell–Inflamed Gene-Expression Profile, Programmed Death Ligand 1 Expression, and Tumor Mutational Burden Predict Efficacy in Patients Treated With Pembrolizumab Across 20 Cancers: KEYNOTE-028
- (2018) Patrick A. Ott et al. JOURNAL OF CLINICAL ONCOLOGY
- Lineage tracking reveals dynamic relationships of T cells in colorectal cancer
- (2018) Lei Zhang et al. NATURE
- Cancer immunoediting and resistance to T cell-based immunotherapy
- (2018) Jake S. O’Donnell et al. Nature Reviews Clinical Oncology
- Pan-tumor genomic biomarkers for PD-1 checkpoint blockade–based immunotherapy
- (2018) Razvan Cristescu et al. SCIENCE
- Peripheral Blood TCR Repertoire Profiling May Facilitate Patient Stratification for Immunotherapy against Melanoma
- (2018) Sabrina A. Hogan et al. Cancer Immunology Research
- Phase II study of ipilimumab in adolescents with unresectable stage III or IV malignant melanoma
- (2017) Birgit Geoerger et al. EUROPEAN JOURNAL OF CANCER
- IFN-γ–related mRNA profile predicts clinical response to PD-1 blockade
- (2017) Mark Ayers et al. JOURNAL OF CLINICAL INVESTIGATION
- Pediatric Gliomas: Current Concepts on Diagnosis, Biology, and Clinical Management
- (2017) Dominik Sturm et al. JOURNAL OF CLINICAL ONCOLOGY
- Clinical applications of PD-L1 bioassays for cancer immunotherapy
- (2017) Delong Liu et al. Journal of Hematology & Oncology
- International incidence of childhood cancer, 2001–10: a population-based registry study
- (2017) Eva Steliarova-Foucher et al. LANCET ONCOLOGY
- Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study
- (2017) Michael J Overman et al. LANCET ONCOLOGY
- Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse Cancers
- (2017) Aaron M. Goodman et al. MOLECULAR CANCER THERAPEUTICS
- A neoantigen fitness model predicts tumour response to checkpoint blockade immunotherapy
- (2017) Marta Łuksza et al. NATURE
- Elements of cancer immunity and the cancer–immune set point
- (2017) Daniel S. Chen et al. NATURE
- Neuroblastoma is composed of two super-enhancer-associated differentiation states
- (2017) Tim van Groningen et al. NATURE GENETICS
- The immune contexture in cancer prognosis and treatment
- (2017) Wolf H. Fridman et al. Nature Reviews Clinical Oncology
- Contemporary survival endpoints: an International Diffuse Intrinsic Pontine Glioma Registry study
- (2017) Tabitha Cooney et al. NEURO-ONCOLOGY
- CBTRUS Statistical Report: Primary brain and other central nervous system tumors diagnosed in the United States in 2010–2014
- (2017) Quinn T Ostrom et al. NEURO-ONCOLOGY
- Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
- (2017) Jedd D. Wolchok et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tumor Mutational Burden and Response Rate to PD-1 Inhibition
- (2017) Mark Yarchoan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Patterns of PD-1, PD-L1, and PD-L2 expression in pediatric solid tumors
- (2017) Navin Pinto et al. PEDIATRIC BLOOD & CANCER
- Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
- (2017) Dung T. Le et al. SCIENCE
- Targeting the PD-1 pathway in pediatric solid tumors and brain tumors
- (2017) Lars Wagner et al. OncoTargets and Therapy
- Immune profiling of NF1-associated tumors reveals histologic subtype distinctions and heterogeneity: Implications for immunotherapy
- (2017) Kellie B. Haworth et al. Oncotarget
- Expression and clinical association of programmed cell death-1, programmed death-ligand-1 and CD8+ lymphocytes in primary sarcomas is subtype dependent
- (2017) Anke E.M. van Erp et al. Oncotarget
- Prognostic relevance of tumor-infiltrating lymphocytes and immune checkpoints in pediatric medulloblastoma
- (2017) Jeroen F. Vermeulen et al. OncoImmunology
- Gene expression markers of Tumor Infiltrating Leukocytes
- (2017) Patrick Danaher et al. Journal for ImmunoTherapy of Cancer
- Programmed Death-Ligand 1 Expression and Response to the Anti–Programmed Death 1 Antibody Pembrolizumab in Melanoma
- (2016) Adil I. Daud et al. JOURNAL OF CLINICAL ONCOLOGY
- Relapse patterns and outcome after relapse in standard risk medulloblastoma: a report from the HIT-SIOP-PNET4 study
- (2016) Magnus Sabel et al. JOURNAL OF NEURO-ONCOLOGY
- Immunoscore and Immunoprofiling in cancer: an update from the melanoma and immunotherapy bridge 2015
- (2016) J. Galon et al. Journal of Translational Medicine
- Landscape of tumor-infiltrating T cell repertoire of human cancers
- (2016) Bo Li et al. NATURE GENETICS
- Low Frequency of Programmed Death Ligand 1 Expression in Pediatric Cancers
- (2016) Takahiro Aoki et al. PEDIATRIC BLOOD & CANCER
- Neuroblastoma
- (2016) Katherine K. Matthay et al. Nature Reviews Disease Primers
- Immune infiltration and PD-L1 expression in the tumor microenvironment are prognostic in osteosarcoma
- (2016) Pratistha Koirala et al. Scientific Reports
- PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
- (2015) Dung T. Le et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer
- (2015) N. A. Rizvi et al. SCIENCE
- RANKL blockade prevents and treats aggressive osteosarcomas
- (2015) Yan Chen et al. Science Translational Medicine
- Tumor-infiltrating T lymphocytes improve clinical outcome of therapy-resistant neuroblastoma
- (2015) Marco Mina et al. OncoImmunology
- PD-L1 and CD8+PD1+lymphocytes exist as targets in the pediatric tumor microenvironment for immunomodulatory therapy
- (2015) Ferdousi Chowdhury et al. OncoImmunology
- Tumor-Associated Macrophages in SHH Subgroup of Medulloblastomas
- (2014) A. S. Margol et al. CLINICAL CANCER RESEARCH
- Combinations of Radiation Therapy and Immunotherapy for Melanoma: A Review of Clinical Outcomes
- (2014) Christopher A. Barker et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Enhancement of an anti-tumor immune response by transient blockade of central T cell tolerance
- (2014) Imran S. Khan et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Therapeutic implications of CD1d expression and tumor-infiltrating macrophages in pediatric medulloblastomas
- (2014) Wan-Yee Teo et al. JOURNAL OF NEURO-ONCOLOGY
- Pediatric and adult malignant peripheral nerve sheath tumors: an analysis of data from the surveillance, epidemiology, and end results program
- (2014) E. Susan Amirian et al. JOURNAL OF NEURO-ONCOLOGY
- Immune-based therapies for childhood cancer
- (2014) Crystal L. Mackall et al. Nature Reviews Clinical Oncology
- Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma
- (2014) Alexandra Snyder et al. NEW ENGLAND JOURNAL OF MEDICINE
- Characterization of Distinct Immunophenotypes across Pediatric Brain Tumor Types
- (2013) A. M. Griesinger et al. JOURNAL OF IMMUNOLOGY
- The additional facet of immunoscore: immunoprofiling as a possible predictive tool for cancer treatment
- (2013) Paolo A Ascierto et al. Journal of Translational Medicine
- The Effect of Age on Thymic Function
- (2013) Donald B. Palmer Frontiers in Immunology
- HLA-DR expression on myeloid cells is a potential prognostic factor in patients with high-risk neuroblastoma
- (2013) Madhu Gowda et al. OncoImmunology
- Selection of Self-Reactive T Cells in the Thymus
- (2012) Gretta L. Stritesky et al. Annual Review of Immunology
- B7-H3, a potential therapeutic target, is expressed in diffuse intrinsic pontine glioma
- (2012) Zhiping Zhou et al. JOURNAL OF NEURO-ONCOLOGY
- CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2005-2009
- (2012) T. A. Dolecek et al. NEURO-ONCOLOGY
- Pediatric sarcomas: translating molecular pathogenesis of disease to novel therapeutic possibilities
- (2012) Jennifer L. Anderson et al. PEDIATRIC RESEARCH
- Increased Microglia/Macrophage Gene Expression in a Subset of Adult and Pediatric Astrocytomas
- (2012) Jane R. Engler et al. PLoS One
- Indoleamine 2,3 dioxygenase and metabolic control of immune responses
- (2012) David H. Munn et al. TRENDS IN IMMUNOLOGY
- Diffuse intrinsic pontine gliomas: A systematic update on clinical trials and biology
- (2011) M.H.A. Jansen et al. CANCER TREATMENT REVIEWS
- Prognostic Factors After Relapse in Nonmetastatic Rhabdomyosarcoma: A Nomogram to Better Define Patients Who Can Be Salvaged With Further Therapy
- (2011) Julia C. Chisholm et al. JOURNAL OF CLINICAL ONCOLOGY
- Distinct signatures of the immune responses in low risk versus high risk neuroblastoma
- (2011) Madhu Gowda et al. Journal of Translational Medicine
- Clinical significance and regulation of the costimulatory molecule B7-H3 in human colorectal carcinoma
- (2010) Jing Sun et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Immunity, Inflammation, and Cancer
- (2010) Sergei I. Grivennikov et al. CELL
- Pro-inflammatory chemokine-chemokine receptor interactions within the Ewing sarcoma microenvironment determine CD8+ T-lymphocyte infiltration and affect tumour progression
- (2010) Dagmar Berghuis et al. JOURNAL OF PATHOLOGY
- Comparing children and adults with synovial sarcoma in the Surveillance, Epidemiology, and End Results program, 1983 to 2005
- (2009) Iyad Sultan et al. CANCER
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now